Published in World J Gastroenterol on April 28, 2013
Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer (2013) 0.97
Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients. J Cancer (2014) 0.82
Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. World J Gastroenterol (2015) 0.81
Liver transplantation for hepatocellular carcinoma: past, present and future. Middle East J Dig Dis (2013) 0.79
Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis. Oncotarget (2017) 0.75
Management of hepatocellular carcinoma in the elderly. World J Hepatol (2015) 0.75
Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review. World J Gastroenterol (2015) 0.75
Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma (2016) 0.75
Spontaneous hepaticoduodenal and choledochoduodenal fistula mimicking duodenal ulcer perforation, a very rare complication of transarterial chemoembolization. Case Rep Gastroenterol (2015) 0.75
Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma. World J Gastroenterol (2015) 0.75
Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects. Hepatobiliary Surg Nutr (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 16.93
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology (2002) 5.71
Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev (2011) 3.73
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. Eur J Radiol (2008) 1.33
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut (2010) 1.29
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. Eur J Radiol (2011) 1.09
Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 1.08
The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer (2009) 1.01
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol (2002) 0.99
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol (2006) 0.96
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC). Oncologist (2011) 0.93
A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Oncologist (2011) 0.91
Hepatocellular carcinoma in older adults: clinical features, treatments, and survival. J Am Geriatr Soc (2011) 0.89
Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors. Dig Liver Dis (2009) 0.89
Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency. J Clin Gastroenterol (2010) 0.87
Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis (2011) 0.85
Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor. J Gerontol A Biol Sci Med Sci (1997) 0.83
[Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years]. Rev Esp Enferm Dig (2008) 0.83
Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med (2011) 16.93
Telaprevir for retreatment of HCV infection. N Engl J Med (2011) 10.48
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med (2006) 5.65
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology (2005) 3.32
Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol (2015) 3.01
The global impact of vaccination against hepatitis B: a historical overview. Vaccine (2008) 2.84
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med (2010) 2.47
Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology (2004) 2.44
Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38
Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J (2010) 2.29
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med (2008) 2.24
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol (2006) 2.19
Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA (2005) 2.18
Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol (2011) 1.96
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96
Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood (2002) 1.87
Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol (2007) 1.79
Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis (2012) 1.73
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis (2006) 1.69
Multiple casualty terror events: the anesthesiologist's perspective. Anesth Analg (2004) 1.68
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine (2006) 1.66
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol (2007) 1.65
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.64
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis (2012) 1.62
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int (2011) 1.57
Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons. MMWR Surveill Summ (2002) 1.57
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology (2002) 1.57
Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology (2011) 1.55
Irrigation of the bile ducts with chilled saline during percutaneous radiofrequency ablation of a hepatic ocular melanoma metastasis. AJR Am J Roentgenol (2004) 1.48
The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine (2011) 1.44
Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003. Emerg Infect Dis (2012) 1.43
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther (2009) 1.39
Caustic sclerosing cholangitis treated with orthotopic liver transplantation. Isr Med Assoc J (2002) 1.38
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis (2011) 1.38
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine (2002) 1.36
Clinical applications of physical 3D models derived from MDCT data and created by rapid prototyping. AJR Am J Roentgenol (2011) 1.36
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons. Virus Res (2004) 1.35
Multisite virological influenza surveillance in India: 2004-2008. Influenza Other Respir Viruses (2011) 1.33
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther (2005) 1.33
Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis (2013) 1.32
Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology (2011) 1.31
Reassortment and evolution of current human influenza A and B viruses. Virus Res (2004) 1.29
Outbreak of influenza A (H3N2) variant virus infection among attendees of an agricultural fair, Pennsylvania, USA, 2011. Emerg Infect Dis (2012) 1.26
Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol (2012) 1.26
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol (2005) 1.24
Complications of high grade liver injuries: management and outcomewith focus on bile leaks. Scand J Trauma Resusc Emerg Med (2012) 1.23
Detection and characterization of clade 7 high pathogenicity avian influenza H5N1 viruses in chickens seized at ports of entry and live poultry markets in Vietnam. Avian Dis (2010) 1.23
Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol (2010) 1.21
Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respir Viruses (2010) 1.21
Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010. Virology (2012) 1.19
Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season. J Infect Dis (2002) 1.17
Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010. Bull World Health Organ (2012) 1.17
HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response. PLoS One (2011) 1.13
Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt. J Infect Public Health (2009) 1.13
Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis (2002) 1.12
Massive abdominal wall hemorrhage from injury to the inferior epigastric artery: a retrospective review. J Vasc Interv Radiol (2008) 1.11
Influenza A and B infection in children in urban slum, Bangladesh. Emerg Infect Dis (2007) 1.11
Facing the new threats of terrorism: radiologists' perspectives based on experience in Israel. Radiology (2005) 1.10
Providing more through less: current methods of retraction in SIMIS and NOTES cholecystectomy. Surg Endosc (2009) 1.09
Transmission of influenza A viruses between pigs and people, Iowa, 2002-2004. Influenza Other Respir Viruses (2010) 1.09
Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology (2006) 1.09
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine (2006) 1.08
Lateral decubitus position for percutaneous nephrolithotripsy in the morbidly obese or kyphotic patient. J Endourol (2002) 1.08
Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells. J Immunol (2006) 1.05
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
Presentation, diagnosis, and management of arterial mycotic pseudoaneurysms in injection drug users. Ann Vasc Surg (2002) 1.02
Immunosuppression and HBV reactivation. Semin Liver Dis (2013) 1.01
Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008. Influenza Other Respir Viruses (2009) 0.99
Highly pathogenic avian influenza A(H7N3) virus in poultry workers, Mexico, 2012. Emerg Infect Dis (2013) 0.99
Increased prevalence of HBV envelope mutants in Taiwan: an emerging public health risk or a false alarm? Gastroenterology (2012) 0.98
Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol (2002) 0.97
Adalimumab-induced autoimmune hepatitis. J Clin Gastroenterol (2010) 0.97
Assessment of development of resistance to antivirals in the ferret model of influenza virus infection. J Infect Dis (2003) 0.97
Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004. Arch Virol (2009) 0.97
Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs. J Vasc Interv Radiol (2008) 0.96
Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortants. Virology (2013) 0.96
Shortening and migration of Wallstents after stenting of central venous stenoses in hemodialysis patients. Cardiovasc Intervent Radiol (2003) 0.95
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C. Hepatology (2008) 0.95
Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology (2012) 0.94
A high diversity of Eurasian lineage low pathogenicity avian influenza A viruses circulate among wild birds sampled in Egypt. PLoS One (2013) 0.94
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature. Liver Int (2004) 0.93
Early detection of pandemic (H1N1) 2009, Bangladesh. Emerg Infect Dis (2012) 0.93
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Pediatr Infect Dis J (2003) 0.93
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology (2002) 0.92
CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol (2013) 0.92
HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes. Virus Res (2007) 0.92
Human metapneumovirus infection among children, Bangladesh. Emerg Infect Dis (2007) 0.92
Surveillance of influenza in Indonesia, 2003–2007. Influenza Other Respir Viruses (2013) 0.92
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology (2011) 0.92
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. Gastroenterology (2013) 0.92
Avian influenza in wild birds, central coast of Peru. Emerg Infect Dis (2009) 0.92